2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004

Press Releases

11/29/2007 - Accuray Incorporated Named as Technology Pioneer 2008 by the World Economic Forum
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the World Economic Forum has selected Accuray as a Technology Pioneers for 2008.

11/27/2007 - Shanghai’s First CyberKnife System Installed at Major Academic Oncology Center
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Hua Shan Hospital in Shanghai has installed a CyberKnife® Robotic Radiosurgery System for its Pudong District facility.

11/26/2007 - Accuray’s CEO to speak at Piper Jaffray 19TH Annual Health Care Conference
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and chief executive officer, Euan S. Thomson, Ph.D., is scheduled to present a corporate update at Piper Jaffray’s Health Care Conference at the Pierre Hotel in New York City, on Tuesday, November 27, 2007 at 12:30 p.m. EST (9:30 a.m. PST).

11/19/2007 - Leading Russian Cancer Center Acquires CyberKnife System
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the N. N. Blokhin Cancer Research Center in Moscow, Russia has acquired a CyberKnife® Robotic Radiosurgery System.

11/15/2007 - Accuray Exceeds 4,000 Lung Cancer Patients Treated With CyberKnife System
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that its CyberKnife® Robotic Radiosurgery System has been used to treat more than 4,000 lung cancer patients worldwide.

11/07/2007 - Accuray Reports Record Revenue in First Quarter of Fiscal 2008
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced financial results for the first quarter of fiscal 2008, ended September 29, 2007.

10/30/2007 - Accuray Enters Partnership with Still River Systems
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company has entered into a partnership with Still River Systems, developer of high quality, cost-effective proton beam radiotherapy solutions, and will provide them with a robotic patient positioning system.

10/29/2007 - Accuray Announces Four New Products at Nation’s Leading Radiation Oncology Meeting
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today four new products designed to improve treatment times, optimize treatment planning objectives and offer greater clinical flexibility in radiation delivery. These products are being launched at the 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Los Angeles.

10/26/2007 - M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife Radiosurgery for Operable Lung Cancer Patients
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company is partnering with The University of Texas M. D. Anderson Cancer Center in Houston, Texas to launch a prospective clinical study to compare treatment outcomes in early-stage operable lung cancer. Patients in the study will be randomly assigned to traditional surgery or CyberKnife® Robotic Radiosurgery for their treatment.

10/24/2007 - U.S. Government Purchases CyberKnife System for Houston VA Hospital
Accuray Incorporated (Nasdaq: ARAY - News), a global leader in the field of radiosurgery, announced today that the U.S. Government has purchased a CyberKnife® Robotic Radiosurgery Systems for the Michael E. DeBakey VA Medical Center in Houston, Texas. The system will be focused on the treatment of extracranial tumors, including lung and prostate.

10/23/2007 - Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO 2007
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that it will host an investor and analyst meeting in conjunction with the 49th Annual Meeting of the American Society of Therapeutic Radiology and Oncology (ASTRO) in Los Angeles on Monday, October 29 from 4:30 p.m. to 6:30 p.m. PDT.

10/12/2007 - Accuray Incorporated to Report First Quarter Fiscal Year 2008 Financial Results
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its first quarter fiscal year 2008, ending September 29, 2007, on Wednesday, November 7, 2007 after the market closes.

10/04/2007 - Hospital Corporation of America Purchases Seventh CyberKnife System
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that leading healthcare services company, Hospital Corporation of America (HCA), has purchased its seventh CyberKnife® Robotic Radiosurgery System for HCA’s The Harley Street Clinic in London, England. This marks HCA’s first non-U.S. CyberKnife System purchase.

10/02/2007 - Accuray to Webcast Senior Management Presentations at Analyst Day Event
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will provide a live webcast for its first ever Analyst Day event, and media and investors are invited to listen to it beginning at 9:00 a.m. PT (12:00 p.m. ET) on Thursday, October 4, 2007.  The Analyst Day will include a series of presentations by members of the Company’s senior management team.  The management presentations and the webcast are expected to conclude at approximately 12:00 p.m. PT (3:00 p.m. ET). 

09/25/2007 - CyberKnife System Shows Momentum as Treatment Option for Prostate Cancer
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that more than 1,000 men have been treated for prostate cancer with the CyberKnife® Robotic Radiosurgery System. As the number of facilities worldwide offering CyberKnife treatments has grown more than 65 percent in the last year, the CyberKnife System is showing tremendous momentum as an alternative to surgery or other conventional prostate cancer treatments.

09/24/2007 - Accuray Incorporated's CEO to Speak at UBS Global Life Sciences Conference
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and CEO, Euan S. Thomson, Ph.D., is scheduled to present a corporate update at the UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York City, on Tuesday, September 25, 2007 at 1:30 p.m. EDT.

09/10/2007 - Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its Monte Carlo Dose Calculation algorithm has received 510(k) clearance from the U.S. Food and Drug Administration and is now commercially available worldwide. This announcement was made as part of the product’s launch at the 9th Biennial European Society for Therapeutic Radiology and Oncology (ESTRO) meeting on Physics and Radiation Technology for Clinical Radiotherapy in Barcelona, Spain.

08/30/2007 - Accuray Board Approves Stock Repurchase Plan
Accuray Incorporated (Nasdaq: ARAY), today announced that its Board of Directors has approved a plan that authorizes the Company to repurchase shares of its common stock. Under the plan, the Company will have the ability to acquire up to $25 million of common shares in the open market over a period of one year. Accuray currently has 53.8 million shares outstanding.

08/16/2007 - Accuray Reports Record Revenue in Fiscal Fourth Quarter and Fiscal Year Ended 2007
Accuray Incorporated (Nasdaq: ARAY), the global leader in radiosurgery throughout the body, today announced financial results for the fiscal fourth quarter and full fiscal year ended June 30, 2007.

08/08/2007 - CyberKnife System Extracranial Treatments Grow 75 Percent in Fiscal Year 2007 Demonstrating Radiosurgery Market Shift
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that use of its CyberKnife® Robotic Radiosurgery System to treat extracranial tumors non-invasively has increased by 75 percent worldwide during Accuray’s fiscal year ending June 30, 2007. The most dramatic growth was seen in the treatment of lung and prostate cancer in the United States, which doubled and quadrupled respectively since the end of fiscal year 2006.

07/23/2007 - Accuray’s Xsight Lung Tracking System Gains Clinical Acceptance as U.S. Adoption Rate Exceeds 97 Percent
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Accuray’s Xsight™ Lung Tracking System, a system designed for the non-invasive treatment of lung tumors, is quickly gaining clinical acceptance with more than 97 percent of new U.S. customers including Xsight Lung in their purchase of a new CyberKnife® Robotic Radiosurgery System. Further extending the CyberKnife System’s suite of products targeted toward the treatment of lung tumors is Accuray’s Monte Carlo dose calculation algorithm, which is pending FDA 510(k) clearance.

07/16/2007 - Accuray Incorporated to Report Fiscal Fourth Quarter and Full Fiscal Year 2007 Financial Results on August 16, 2007
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced it will report results for its fourth quarter fiscal year 2007 ending June 30, 2007 and full fiscal year 2007 ending June 30, 2007 on Thursday, August 16, 2007, after the market closes.

06/20/2007 - 100 Percent of U.S. CyberKnife Installed Base Treating Extracranial Tumors
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced the latest utilization data confirming that 100 percent of CyberKnife® centers in the United States are treating extracranial tumors. Of specific importance is that treatments of lung and prostate cancers are on the rise at CyberKnife facilities.

06/06/2007 - Multiple Hospitals Acquire Second CyberKnife System to Meet Growing Demand for Radiosurgery
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Georgetown University Hospital’s second CyberKnife® Robotic Radiosurgery System has arrived at its Lombardi Comprehensive Cancer Center in Washington, D.C. The system is expected to begin treating patients in July 2007. Georgetown is one of many centers with a second CyberKnife System installed or pending installation in the coming months to meet the growing demand for radiosurgery.

05/31/2007 - Health Technology Assessment Validates Extracranial Radiosurgery Treatments Particularly Those Delivered with CyberKnife
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the French High Authority of Health – Haute Autorité de Santé (HAS) – issued a health technology assessment report validating extracranial radiosurgery treatment applications, particularly those delivered with the CyberKnife® Robotic Radiosurgery System. The report deemed clinical benefits with these extracranial applications a significant improvement compared to existing alternatives (2 on a scale of 5, with 1 being the most significant).

05/14/2007 - Accuray Amends Announcement of its Fiscal Third Quarter 2007 Financial Results
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today issued an amended announcement of its fiscal third quarter 2007 financial results originally issued in a press release on May 1, 2007.

05/08/2007 - CyberKnife Installed Base Reaches 100 Systems Worldwide as Field of Radiosurgery Continues to Expand
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the CyberKnife® Robotic Radiosurgery System install base has reached 100 systems. This milestone was reached following the installation at Centre Oscar Lambret in Lille, France. To date, it is estimated that more than 30,000 patients worldwide have been treated with the CyberKnife System, which provides a non-surgical treatment alternative for many cancer patients.

05/01/2007 - Accuray Reports Fiscal Third Quarter 2007 Financial Results
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced financial results for the fiscal third quarter ended March 31, 2007.

04/30/2007 - CyberKnife Technology May Provide Non-invasive Means for Cardiac Ablation
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that it has entered into an agreement with CyberHeart Incorporated under which CyberHeart will use Accuray’s technology to develop a non-invasive method for performing cardiac ablation. Cardiac ablation is used to destroy a small portion of the heart that is causing abnormal rhythms. Ultimately, the developed technology may have applications in the treatment of atrial fibrillation, a disorder that prevents the heart from beating properly and can cause blood clots and strokes.

04/17/2007 - Accuray Incorporated to Report Third Quarter Fiscal Year 2007 Financial Results on May 1, 2007
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced it will report results for its third quarter fiscal year 2007 on Tuesday, May 1, 2007, after the market closes.

04/11/2007 - Accuray Signs Distribution and Co-Marketing Agreement with Siemens
Accuray Incorporated, a global leader in the field of radiosurgery, today announced that it has signed a co-marketing and distribution agreement with Siemens Medical Solutions USA, Inc. The agreement enables Accuray to integrate its CyberKnife® Robotic Radiosurgery System and RoboCouch™ Patient Positioning System with a Siemens SOMATOM® computed tomography (CT) scanner with a sliding gantry configuration. The combination of these technologies in the treatment room further enhances visibility of internal structures at the time of treatment.

04/03/2007 - Accuray Surpasses 2,000 Lung Cancer Patients Treated with the CyberKnife Robotic Radiosurgery System
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that its CyberKnife® Robotic Radiosurgery System has been used to treat more than 2,000 lung cancer patients worldwide. The company also reported that the first patient was treated using the recently introduced Xsight™ Lung Tracking System, a system that works with the CyberKnife System to precisely track and treat some lung tumors non-invasively.

03/19/2007 - Survey Confirms the CyberKnife System as the Only Extracranial Radiosurgery Device in Widespread Use
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today the results of an independent survey that confirms that the CyberKnife® Robotic Radiosurgery System dominates the field of extracranial radiosurgery. The survey concludes that hospitals with combined radiotherapy and radiosurgery systems, also known as “all-purpose” units, are rarely utilizing the extracranial radiosurgery capabilities.  In fact, the survey, which included more than 1,600 hospitals and radiation oncology facilities, shows that for 88 percent of the all-purpose systems in use today, less than 10 percent of the procedures were extracranial radiosurgery.

03/15/2007 - Accuray Incorporated Reports Second Quarter Fiscal 2007 Financial Results
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of robotic radiosurgery, today announced financial results for the second quarter ended December 30, 2006. Total net revenues were $26.3 million for the quarter ended December 30, 2006, as compared to $11.3 million for the quarter ended December 31, 2005, an increase of 133 percent.

02/20/2007 - CyberKnife Spinal Tumor Treatments Increase by 56 Percent
Accuray Incorporated, a global leader in the field of radiosurgery, announced clinical data that shows use of its CyberKnife® Robotic Radiosurgery System in the treatment of spinal tumors has increased by 56 percent between December 2005 and December 2006. Success of this non-invasive procedure, which avoids potential damage to the spinal cord, is further validated by a study of 500 spinal tumor patients. The study results were published in the January 15 issue of the journal Spine.

02/13/2007 - Accuray Incorporated Announces Underwriters' Exercise of Over-Allotment Option and Completion of Initial Public Offering
Accuray Incorporated (Nasdaq: ARAY) today announced the closing of its initial public offering of common stock and the exercise by the underwriters of their over-allotment option to purchase an additional 2,399,998 shares, of which 2,000,000 were sold by certain selling stockholders of the Company, and 399,998 were sold by the Company. Including the over-allotment amount, a total of 18,399,998 shares were sold in the initial public offering.

02/08/2007 - Accuray Incorporated Announces Pricing Of Initial Public Offering
Accuray Incorporated (NASDAQ: ARAY) today announced the initial public offering of 16,000,000 shares of common stock, of which 10,000,000 are being sold by the Company and 6,000,000 are being sold by certain stockholders of the Company, at $18.00 per share.  Accuray and the selling stockholders have granted the underwriters an option to purchase up to an additional 399,998 and 2,000,000 shares, respectively, at the initial public offering price to cover over-allotments, if any.  The common stock will trade on the NASDAQ Global Market under the symbol ARAY.